JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
107.000 |
Evidence |
O
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
BMX |
IPI00514142 |
107.000 |
Evidence |
|
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
JAK1 |
|
106.000 |
Evidence |
O
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
106.000 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
CSK |
CSK: Tyrosine-protein kinase CSK |
106.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
106.000 |
Evidence |
|
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
STAT3 |
|
106.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
SYK |
SYK: Tyrosine-protein kinase SYK |
106.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
LYN |
LYN: Tyrosine-protein kinase Lyn |
106.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
JAK1 |
|
106.000 |
Evidence |
|
PDHA1 |
PDHA1, PHE1A: Pyruvate dehydrogenase E1 component subunit alpha, somatic form, m |
DLAT |
Dihydrolipoamide S-acetyltransferase (Fragment) |
106.000 |
Evidence |
O
|
POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
106.000 |
Evidence |
O
|
POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
POLR2B |
POLR2B: DNA-directed RNA polymerase II subunit RPB2 |
106.000 |
Evidence |
O
|
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
CFL1 |
CFL1, CFL: Cofilin-1 |
105.000 |
Evidence |
O
|
EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
105.000 |
Evidence |
O
|
POLR1C |
POLR1C, POLR1E: DNA-directed RNA polymerases I and III subunit RPAC1 |
POLR2H |
POLR2H: DNA-directed RNA polymerases I, II, and III subunit RPABC3 |
105.000 |
Evidence |
O
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
105.000 |
Evidence |
O
|
CRYAA |
CRYAA, CRYA1, HSPB4: Alpha-crystallin A chain |
CRYBB2 |
CRYBB2, CRYB2, CRYB2A: Beta-crystallin B2 |
105.000 |
Evidence |
O
|
CRYAB |
CRYAB, CRYA2: Alpha-crystallin B chain |
CRYGC |
CRYGC, CRYG3: Gamma-crystallin C |
105.000 |
Evidence |
O
|
RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
104.000 |
Evidence |
|
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
104.000 |
Evidence |
|
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
104.000 |
Evidence |
|